Amalie Leinebø has a MSc in Nanotechnology, with specialization in bionanotechnology, from the Norwegian University of Science and Technology. For her Master’s thesis, she conducted research on electrochemical enzymatic lactate biosensors, completing her thesis in June 2023. Amalie spent one year in the Netherlands at Eindhoven University of Technology on an Erasmus exchange program, taking courses in biomedical engineering and applied physics. Before initiating her MSc, Amalie completed the first year of medical studies at the University of Oslo, obtaining both theoretical and practical experience within human biology and patient interactions. After one year of medical studies, she learned that she wanted to work with biomedical research, and decided to pursue an engineering degree in bionanotechnology.
Since October 2023, Amalie has been a doctoral researcher in the Melomanes project, investigating and evaluating the multiscale biological effects of nanoparticle-induced hyperthermia, multi-modal imaging and immunotherapy in a mouse melanoma model.
